Best Multiple sclerosis Treatment Clinics and Prices in India for Australians

India offers comprehensive Multiple Sclerosis (MS) care. This includes disease-modifying therapies, plasma exchange, and ocrelizumab infusions. JCI-accredited centres like Apollo Hospital Indraprastha and Artemis Hospitals provide integrated neurology services. Treatments range from acute relapse management with corticosteroids to neuro-rehabilitation and neuro-regenerative approaches.

• Infusion therapies: High-efficacy monoclonal antibodies such as ocrelizumab are available in hospital units.
• Specialised procedures: Specialists perform plasmapheresis to filter blood during severe flare-ups.
• Diagnostic precision: Centres use brain MRI with contrast to track nerve fibre scarring.
• Neuro-rehabilitation: Dedicated programmes focus on gait correction and muscle strength at specialised clinics.

Bookimed Expert Insight: While many centres offer standard care, choosing a facility in a major metro ensures better access. Cities like Delhi or Mumbai offer the Full Time Specialist System. Clinics like Kokilaben Dhirubhai Ambani Hospital use this model to guarantee neurologist availability for urgent relapse management.

Patient Consensus: Patients note that drug availability varies by city. They advise confirming specific brand registrations before travel. Those visiting India emphasise coordinating a long-term plan for continuing infusions after returning to Australia.

Autologous Haematopoietic Stem Cell Transplantation (HSCT) for Multiple Sclerosis is available in India at several JCI-accredited facilities. Specialist teams at centres like BLK Super Speciality Hospital and Apollo Hospital Indraprastha perform this procedure. It is most effective for aggressive relapsing-remitting cases with active inflammation.

• Specialist centres: BLK Super Speciality Hospital and Global Hospital Chennai specialise in bone marrow transplants.
• Accreditation standards: Leading facilities like Artemis Hospitals hold JCI accreditation for international safety protocols.
• Patient eligibility: Candidates typically need an Expanded Disability Status Scale (EDSS) score under 7.0.
• Clinical volume: Apollo Hospital Indraprastha serves over 1,000,000 international patients annually across its medical network.

Bookimed Expert Insight: India's largest medical networks provide a significant institutional advantage for complex transplants. For example, Manipal Hospitals operates 15 sites and serves 2,000,000 patients annually. This massive volume helps Indian haematologists maintain high proficiency in isolation protocols and neutropenic care. Patients should prioritse these high-volume networks which hold quality markers like NABH and ISO certification.

Patient Consensus: Patients emphasise the need to confirm that the facility offers autologous HSCT specifically. This is different from general stem cell therapy. They note it is vital to verify the haematology team’s experience with Multiple Sclerosis cases in India.

Multiple sclerosis treatment in India is best sought at JCI-accredited facilities like Artemis Hospitals and Apollo Hospital Indraprastha. These centres provide disease-modifying therapies and plasmapheresis. Dedicated departments offer specialised neuro-rehabilitation and neuro-immunology clinics for comprehensive care.

• Diagnostic excellence: Hospitals use high-resolution brain MRI with contrast to track lesions.
• Advanced therapy: Centres provide monoclonal antibody infusions such as ocrelizumab for relapses.
• Integrated rehabilitation: Specialist teams offer neuro-physiotherapy to help restore physical mobility.
• Specialist access: Systems like Kokilaben Hospital provide full-time access to senior neurologists.

Bookimed Expert Insight: Indian medical networks such as Manipal and Apollo serve over 1,000,000 patients annually. This massive scale allows doctors like Dr Hitesh Kumar to manage rare neuro-immunological variations regularly. Patients should choose Gurgaon or Delhi hubs where these large neurological departments are concentrated.

Neuro-rehabilitation in India provides integrated support for multiple sclerosis through specialised hospital networks and dedicated clinics. Patients access physical, occupational, and speech therapies alongside treatments like plasmapheresis. JCI-accredited facilities in Delhi, Mumbai, and Bengaluru offer structured inpatient and outpatient programmes focused on functional recovery.

• Multidisciplinary approach: Teams manage spasticity, pain, and cognitive issues through tailored exercise plans.
• Diagnostics: Clinics use high-resolution MRI and PET-CT scans to monitor disease progression.
• Specialised specialists: Doctors like Dr Hitesh Kumar at Artemis Hospitals specialise in complex neurology.
• Large-scale infrastructure: Manipal Hospitals serves 2,000,000 patients annually with extensive neuro-rehab departments.

Bookimed Expert Insight: Patients seeking intensive recovery should target JCI-accredited networks like Apollo or Manipal Hospitals. These major groups serve over 1,000,000 patients annually. Internal data shows they offer more comprehensive physical therapy equipment than smaller private centres. Their NABL-accredited labs are vital for Australians requiring internationally recognised monitoring of Ocrevus.

Patient Consensus: Patients note it is important to look for Indian city subreddits. These often mention local gait training and neurologic clinics. Many find that multi-specialty physiotherapy centres provide a more personalised atmosphere for long-term maintenance.

Health insurance for multiple sclerosis treatment in India is restrictive and often excludes outpatient care. Policies usually involve lump-sum critical illness payouts or hospitalisation indemnity. Patients must serve a 2 to 4 year waiting period for pre-existing conditions. Standard plans rarely cover ongoing oral medications.

• Hospitalisation coverage: Standard policies pay for inpatient stays, steroid infusions, or surgeries.
• Critical illness payout: Diagnostic confirmation triggers a one-time lump-sum payment for rehabilitation or care.
• Waiting periods: Diagnosed patients face 2 to 5 years before insurance honours MS-related claims.
• Out-of-pocket costs: Patients typically pay for outpatient MRIs, physical therapy, and daily oral drugs.

Bookimed Expert Insight: JCI-accredited hubs like Apollo Hospital Indraprastha and Manipal Hospitals handle large international volumes. Apollo alone serves 1,000,000 patients annually. While insurance is complex, generic biosimilars in India significantly reduce the financial burden. This helps those paying without full coverage.

Patient Consensus: Patients in India suggest getting insurer pre-approval in writing. They also recommend verifying if the hospital offers direct billing. Many facilities require upfront payment with reimbursement occurring after returning home.